biOasis Technologies Ord Shs V.BTI.H

Alternate Symbol(s): BIOAF

Healthcare Biotechnology

Bioasis Technologies Inc. is a Canada-based biopharmaceutical company focused on research and development of technologies and products intended for the treatment of patients with nervous system, including central nervous system, diseases and disorders. The Company is engaged in the development of its xB 3 platform, which is a peptide-based technology, for the transport of therapeutic agents, in particular biological products, across the blood-brain barrier (BBB). It is focused on both orphan drug indications, including brain cancers, and rare genetic neurodegenerative diseases and neuroinflammatory conditions. The Company is also focused on its Epidermal Growth Factor (EGF) platform for treating rare and orphan neurodegenerative and neuroinflammatory disorders. EGF is a protein that stimulates cell growth and differentiation, notably for myelin producing cells. Its development programs include xB3-001: Brain Metastases, xB3-002: Glioblastoma and xB3-007: Neurodegenerative Disease.

TSXV:BTI.H - Post by User

biOasis Technologies Ord Shs > PROTHENA?

<< Previous

Bullboard Posts

Next >>

Comment by greaterfoolFredon Apr 06, 2021 10:17am

150 Views

Post# 32941015

RE:PROTHENA?

There might be an announcement in the future, since I don't think that we are going to walk away because Prothena are late making a decision. But if they have walked away from us, we will probably have to wait for prophet to deduce it from some footnote in someone's company report.

<< Previous

Bullboard Posts

Next >>

POET increases production capacity to meet AI demand